Refine by
Patient Provider Engagement Articles & Analysis
39 news found
(TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering treatments for no-option patients in Florida suffering from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease, Angina, Ischemic Cardiomyopathy, non Ischemic Dilated Cardiomyopathy, and Congestive Heart Failure, is pleased to announce ...
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM, OTCQB: HMTXF; FSE:2VF0), the leading autologous (patient’s own) stem cell therapy company treating no-option patients in Florida suffering in pain from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease and Angina, is pleased to announce its webinar topic for Thursday, August 21, 2025. Croom ...
Summary Dentists and surgeons devote their professional lives to improving patient health, often engaging in complex procedures that require precision, concentration, and prolonged static or awkward positioning. However, inadequate ergonomics can result in chronic pain, musculoskeletal disorders (MSDs), fatigue, and shortened careers, with studies indicating ...
The HFSA Optimal Medical Therapy in Heart Failure (OMT-HF) program can help your patients achieve their best outcomes. An estimated 6.5 million Americans have heart failure (HF). This year alone another 960,000 will likely be diagnosed with this condition. Chances are several of your patients are in this group. Are they receiving the optimal medical therapy (OMT), that helps them achieve ...
Longenesis will enrich its digital educational engagement platform skrinings.lv by providing its network of participants discounted Dante offerings, including at-home, blood collection kits for WGS without the use of a needle and additional women’s health reports without the need to re-test. ...
“Confidence and peace-of-mind on behalf of providers and patients alike will allow clinicians to provide stronger recommendations and solutions for their ...
“Together with xCures and Faeth Therapeutics, we are looking forward to rapidly recruiting and enrolling patients where they are, reducing recruitment timelines and costs, and increasing patient ...
ByxCures
[ii] Weight monitoring is currently the noninvasive standard of care for detecting fluid changes in patients with heart failure. However, weight gain is a late sign of worsening status, and typically does not provide enough advance warning to deliver an effective intervention that can prevent a hospitalization. ...
” “I am enthusiastic about the prospects for ReShape’s continued growth including its full suite of weight loss solutions, especially the Lap-Band® program and the demand generated by the multi-tiered direct-to-consumer (DTC) marketing campaign, thus far, which continues to be successful in driving patient engagement and filling ...
Longenesis announced its initial partnership to study diabetic patients’ quality of life with Medtronic in 2021. Medical research often suffers from low patient engagement rates due to a lack of individualised engagement options, resulting in a lack of helpful data that healthcare stakeholders can use to make vital care ...
Through Skrinings.lv’s partnership with Longenesis, completely anonymised and private data from the test can be made available to researchers and reproductive health specialists seeking to provide better care to their patients and increase awareness of contraception in their countries. ...
The feedback collected speaks to us of patients who feel involved, engaged, followed, monitored and protected. ...
The Alzheimer's Podcast miniseries provides insights and information for those who are diagnosed with Alzheimer's disease and the people who care about them. ...
Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced the appointment of Dr. Antonella Santuccione Chadha as Chief Medical Officer. In this new role, Dr. Chadha will lead all clinical and medical affairs as the company continues to develop, validate, and commercialize ...
Hitachi, Ltd. (TSE: 6501, Hitachi), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment. One in 10 adults worldwide have been diagnosed with type 2 diabetes, but a smaller number require multiple medications to control blood ...
The Notal Home OCT pipeline technology is designed to provide patient-initiated retinal OCT scans to support the management of patients with wet age-related macular degeneration (AMD), complementing existing standard of care treatments as well as emerging longer acting drugs and drug delivery systems. ...
Isabel Healthcare and Riverwood Healthcare have partnered to integrate Isabel’s AI symptom checker / self-triage platform into the Riverwood website to enhance care access and patient engagement. The symptom checker has been customized for Riverwood with integration of live chat and care option selection links and other pertinent content to help ...
It will be the first proton therapy system in San Antonio and South Texas to provide this advanced alternative to conventional radiation therapy for cancer. ...
Recent Announcements - February 2022: Product On February 2, 2022, we announced Invisalign system innovations for the Align Digital Platform, a proprietary combination of software, systems, and services designed to provide a seamless experience and workflow that integrates and connects all users – doctors, labs, patients, and consumers. ...
Each of these innovations is designed to enhance Invisalign treatment planning quality, efficiency, and scale, and contribute to a better doctor-patient engagement and treatment outcomes. Raj Pudipeddi, Align Technology chief product and marketing officer, senior vice president and managing director, Asia Pacific said, “Align is proud to be at the ...